These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9050795)

  • 21. Mechanism of deiodination of 125I-human growth hormone in vivo. Relevance to the study of protein disposition.
    Wroblewski VJ
    Biochem Pharmacol; 1991 Jul; 42(4):889-97. PubMed ID: 1867644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn rats.
    Feng J; Mehta VB; El-Assal ON; Wu D; Besner GE
    Peptides; 2006 Jun; 27(6):1589-96. PubMed ID: 16364500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional differences in gastrointestinal processing and absorption of epidermal growth factor in suckling rats.
    Rao RK; Koldovský O; Grimes J; Williams C; Davis TP
    Am J Physiol; 1991 Nov; 261(5 Pt 1):G790-8. PubMed ID: 1951698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
    Deguchi Y; Kurihara A; Pardridge WM
    Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of the pharmacokinetics of small proteins by iodination.
    Bauer RJ; Leigh SD; Birr CA; Bernhard SL; Fang M; Der K; Ihejeto NO; Carroll SF; Kung AH
    Biopharm Drug Dispos; 1996 Dec; 17(9):761-74. PubMed ID: 8968529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of epidermal growth factor binding in rat pancreatic acini by palmitoyl carnitine: evidence for Ca2+ and protein kinase C independent regulation.
    Brockenbrough JS; Korc M
    Cancer Res; 1987 Apr; 47(7):1805-10. PubMed ID: 3102049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
    Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
    Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic analysis of clearance of epidermal growth factor in isolated perfused rat kidney.
    Kim DC; Hanano M; Sawada Y; Iga T; Sugiyama Y
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F988-97. PubMed ID: 1750524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
    Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
    J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable?
    Ducongé J; Fernández-Sánchez E; Alvarez D
    Biopharm Drug Dispos; 2004 May; 25(4):177-86. PubMed ID: 15108220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues.
    Kim DC; Sugiyama Y; Satoh H; Fuwa T; Iga T; Hanano M
    J Pharm Sci; 1988 Mar; 77(3):200-7. PubMed ID: 3259628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fate and uptake of murine epidermal growth factor in the sheep.
    Tyson LM; Browne CA; Jenkin G; Thorburn GD
    J Endocrinol; 1989 Oct; 123(1):121-30. PubMed ID: 2809484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution and stability in the rat of a 76Br/125I-labelled polypeptide, epidermal growth factor.
    Scott-Robson S; Capala J; Carlsson J; Malmborg P; Lundqvist H
    Int J Rad Appl Instrum B; 1991; 18(2):241-6. PubMed ID: 2026501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of 125I-labeled epidermal growth factor.
    Matrisian LM; Planck SR; Finch JS; Magun BE
    Biochim Biophys Acta; 1985 Apr; 839(2):139-46. PubMed ID: 3872683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic analysis of the elimination process of human epidermal growth factor (hEGF) in rats.
    Kim DC; Sugiyama Y; Fuwa T; Sakamoto S; Iga T; Hanano M
    Biochem Pharmacol; 1989 Jan; 38(2):241-9. PubMed ID: 2783649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect of iodination of ovotransferrin and its two half-molecule domains on binding to transferrin receptors on chick embryo red blood cells.
    Mason AB; Brown SA
    Biochem J; 1987 Oct; 247(2):417-25. PubMed ID: 3426544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entry of EGF into brain is rapid and saturable.
    Pan W; Kastin AJ
    Peptides; 1999; 20(9):1091-8. PubMed ID: 10499427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H; Tsuji A; Hirai K; Kang YS
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trichloroacetic acid (TCA) precipitability of 125I in the blood of mice fed 125I.
    Harmatz PR; Walsh MK; Walker WA; Hanson DG; Bloch KJ
    J Immunol Methods; 1987 Sep; 102(2):213-9. PubMed ID: 3655373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clearance of rabbit plasma angiotensinogen and relationship to CSF angiotensinogen.
    Lewicki JA; Printz JM; Printz MP
    Am J Physiol; 1983 Apr; 244(4):H577-85. PubMed ID: 6837758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.